Samraat Raha Insider Trades & Stock Holdings

President and CEO · Myriad Genetics, Inc. · Latest filing Jun 11, 2026

Samraat Raha, President and CEO at Myriad Genetics, Inc. has 2 Form 4 trades on file since Jun 11, 2026. Latest filing: acquired 3.54K shares of $MYGN on Jun 11, 2026 at $3.94.

Trades on file

2

Open-market bought

$0

Open-market sold

$0

Net open-market

$0

Latest filing

Jun 11, 2026

All insider trades by Samraat Raha

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 11, 2026	$MYGN	Buy (Grant or award)	3.54K	$3.94	$13.96K						President and CEO		—
Jun 11, 2026	$MYGN	Buy (Grant or award)	3.54K	$3.94	$13.96K						President and CEO		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Samraat Raha traded

• $MYGN

Frequently asked questions

What was Samraat Raha's latest insider trade?

acquired 3.54K shares of $MYGN on Jun 11, 2026 at $3.94.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.